Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roebi de Bruijn
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
Cancer Cell
Cancer Research
Oncology
Cell Biology
Comparative Oncogenomics Identifies Combinations of Driver Genes and Drug Targets in BRCA1-mutated Breast Cancer
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Related publications
Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline
Cell Stem Cell
Molecular Medicine
Genetics
Cell Biology
E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer
Cancer Discovery
Oncology
Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality Towards Discovery of Selective Anticancer Therapies
F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy
Molecular Cell
Cell Biology
Molecular Biology
Candidate Synthetic Lethality Partners to PARP Inhibitors in the Treatment of Ovarian Clear Cell Cancer (Review)
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
The Effect of Green and Black Tea Polyphenols on BRCA2 Deficient Chinese Hamster Cells by Synthetic Lethality Through PARP Inhibition
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Cancer Research
Cancer Research
Oncology
Loss of KDM6A Characterizes a Poor Prognostic Subtype of Human Pancreatic Cancer and Potentiates HDAC Inhibitor Lethality
International Journal of Cancer
Cancer Research
Oncology
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Current Problems in Cancer
Cancer Research
Oncology
